Genomma Lab Internacional, S.A.B. de C.V (LABB.MX) Price-to-Earnings (P/E) Ratio
Price: $24.82
Market Cap: $24.82B
Avg Volume: 3.27M
Market Cap: $24.82B
Avg Volume: 3.27M
Country: MX
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
Genomma Lab Internacional, S.A.B. de C.V's P/E ratios across different time periods:
- TTM: 10.97
- Annual: 11.20
- Quarterly: 12.64
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: 2.07
- Price-to-Sales (P/S) Ratio: 1.29
Annual Ratios
Genomma Lab Internacional, S.A.B. de C.V Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
10.97
P/B Ratio (Annual)
2.07
P/S Ratio (Annual)
1.29
Genomma Lab Internacional, S.A.B. de C.V Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | P/E Ratio | P/B Ratio | P/S Ratio |
|---|---|---|---|
| 2024 | 11.20 | 2.07 | 1.29 |
| 2023 | 12.48 | 1.43 | 0.82 |
| 2022 | 12.06 | 1.65 | 1.00 |
| 2021 | 16.55 | 2.15 | 1.40 |
| 2020 | 13.58 | 1.98 | 1.37 |
| 2019 | 24.62 | 2.36 | 1.48 |
| 2018 | 10.77 | 1.61 | 1.01 |
| 2017 | 15.62 | 2.92 | 1.65 |
| 2016 | -12.56 | 3.21 | 1.87 |
| 2015 | -13.37 | 1.59 | 1.29 |
| 2014 | 20.36 | 2.86 | 2.55 |
| 2013 | 21.90 | 4.43 | 3.39 |
| 2012 | 18.54 | 4.00 | 2.84 |
| 2011 | 20.00 | 5.12 | 3.51 |
| 2010 | 28.17 | 7.54 | 4.92 |
Related Metrics
Explore detailed financial metrics and analysis for LABB.MX.